3-deazaneplanocin has been researched along with Diabetic Nephropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liebisch, M; Wolf, G | 1 |
1 other study(ies) available for 3-deazaneplanocin and Diabetic Nephropathies
| Article | Year |
|---|---|
AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3.
Topics: Adenosine; Animals; Cell Line; Diabetic Nephropathies; Disease Models, Animal; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Glycation End Products, Advanced; Humans; Intracellular Signaling Peptides and Proteins; Mice; Podocytes; RNA, Small Interfering | 2020 |